All In MedTech

FDA Clearance Tracker · P980035-S264

ADVISA DR IPG

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jun 4, 2012 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jun 4, 2012

Approved

Time to decision

89 days

Received Mar 7, 2012. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P980035-S264
Device name
ADVISA DR IPG
Applicant location
Mounds View, MN
Received
Mar 7, 2012
Decided
Jun 4, 2012
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P980035

Device type

Device class
Class III

Every decision under product code NVZ

FDA's approval statement

As written in FDA's record.

ADVISA DR IPG MODEL A4DR01 AND APPLICATION SOFTWARE MODEL 9995 VERSION 7.4 FOR CARELINK PROGRAMMER MODEL 2090.

Source documents

Other decisions for Medtronic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.